Orthofix International N.V. - Board of Directors

James F. Gero
Chairman of the Board of Directors, Director of Intrusion, Inc., Drew Industries, Inc. and Greenleaf, Inc.

Mr. Gero became Chairman of Orthofix International N.V. on Jan. 1, 2005, and has been a Director of Orthofix International N.V. since 1998. Mr. Gero became a Director of AME Inc. in 1990. He is a Director of Intrusion, Inc. and Drew Industries Inc. as well as being a private investor.

Holdings: 122,504 shares View Transactions
Date	Type	Shares Traded	Price Range
Nov 11, 2008	Buy	20,000	12.99
May 8, 2008	Buy	4,500	37.90
May 7, 2008	Buy	3,000	37.24
May 6, 2008	Buy	7,500	36.17
May 11, 2007	Buy	10,000	47.28 - 47.35
Aug 25, 2006	Buy	8,676	39.50 - 39.69
Aug 18, 2006	Buy	15,224	38.78
Aug 17, 2006	Buy	1,100	38.81

Charles W. Federico
Director

Mr. Federico became a Director of Orthofix International N.V. in October 1996 and was the President of Orthofix Inc. from October 1996 to Jan. 1, 2002. On Jan. 1, 2001, Mr. Federico was appointed President and Chief Executive Officer of Orthofix International N.V. From 1985 to 1996, Mr. Federico was the President of Smith & Nephew Endoscopy (formerly Dyonics, Inc.). From 1981 to 1985, Mr. Federico served as Vice President of Dyonics, initially as Director of Marketing and subsequently as General Manager. Previously, he held management and marketing positions with General Foods Corporation, Air Products Corporation, Puritan Bennett Corporation and LSE Corporation. Effective April 1, 2006, Mr. Federico resigned as President and Chief Executive Officer of Orthofix International N.V. but remains on the Board of Directors.

Holdings: 4,325 shares View Transactions
Date	Type	Shares Traded	Price Range
Dec 5, 2006	Sell	43,800	45.00 - 45.20
Dec 5, 2006	Option Execute	43,800	37.76 - 43.04
Aug 31, 2006	Sell	124,900	39.15 - 39.74
Aug 31, 2006	Option Execute	124,900	17.88 - 37.76
Aug 30, 2006	Sell	125,100	39.76 - 39.90
Aug 30, 2006	Option Execute	125,100	17.88

Alan W. Milinazzo
Director, Group President and CEO

Mr. Milinazzo joined Orthofix International in 2005 as Chief Operating Officer and succeeded to the position of CEO the following year. Prior to joining Orthofix, Mr. Milinazzo was Vice President of Medtronic Inc.'s Vascular business, as well as, Vice President and General Manager of Medtronic's Coronary and Peripheral businesses. Prior to his time with Medtronic, Mr. Milinazzo spent 12 years as an executive with Boston Scientific Corporation in numerous roles, including Vice President of Marketing for SCIMED Europe. Mr. Milinazzo brings more than two and a half decades of experience in the management and marketing of medical device businesses, including positions with Aspect Medical Systems and American Hospital Supply. He earned a bachelor's degree, cum laude, at Boston College in 1981.

Jerry C. Benjamin
Director and Chairman of the Audit Committee

Mr. Benjamin became a non-executive Director of Orthofix International N.V. in March 1992. He has been a General Partner of Advent Venture Partners, a venture capital management firm in London since 1985. In the past, Mr. Benjamin was a Director for a number of private healthcare companies.

Chair of the Audit Committee

Walter P. von Wartburg
Director

Dr. von Wartburg became a non-executive Director of Orthofix International N.V. in June 2004. He is an attorney and has practiced privately in his own law firm in Basel, Switzerland since 1999, specializing in life sciences law. He has also been a professor of administrative law and public health policy at the Saint Gall Graduate School of Economics in Switzerland for 25 years. Previously, he held top management positions with Ciba Pharmaceuticals and Novartis at their headquarters in Basel, Switzerland. In addition, Mr. von Wartburg currently serves as a Director on the board of Nymox Pharmaceutical Corporation.

Member of the Nominating and Governance Committee

Thomas J. Kester CPA
Director and Chairman of the Compensation Committee

Mr. Kester became a non-executive Director of Orthofix International N.V. in August 2004. Mr. Kester retired after 28 years, 18 as an audit partner, from KPMG LLP in 2002. While at KPMG, he served as the lead audit engagement partner for both public and private companies and also served four years on KPMG's National Continuous Improvement Committee. Mr. Kester earned a bachelor of science degree in mechanical engineering from Cornell University and an MBA degree from Harvard University.

Member of the Audit Committee

Chair of the Compensation Committee

Holdings: 4,000 shares View Transactions
Date	Type	Shares Traded	Price Range
May 9, 2008	Buy	2,000	33.01 - 33.19
May 14, 2007	Buy	1,000	47.34

Guy Jordan PhD
Director and Chairman of the Governance and Nominating Committee

Dr. Jordan became a non-executive Director of Orthofix International N.V. in December 2004. Most recently, Dr. Jordan served as a group president at CR Bard, Inc., a medical device company, where he had strategic and operating responsibilities for Bard's global oncology business and functional responsibility for all of Bard's research and development. Dr. Jordan earned a Ph.D. in organic chemistry from Georgetown University as well as an MBA from Fairleigh Dickinson University. He also currently serves on the boards of Specialized Health Products International, Inc., Xillix Technologies Corporation and EsophyX, Inc.

Chair of the Nominating and Governance Committee

Member of the Compensation Committee

Kenneth R. Weisshaar
Director

Mr. Weisshaar became a non-executive Director of Orthofix International N.V. in December 2004. Most recently, Mr. Weisshaar has served as Chief Operating Officer and strategy advisor for Sensatex, Inc. Also, Mr. Weisshaar spent 12 years as a corporate officer at Becton Dickson, a medical device company, where at different times he was responsible for global businesses in medical devices and diagnostic products and served as Chief Financial Officer and Vice President, Strategic Planning. Mr. Weisshaar earned a bachelor of science degree from MIT and an MBA from Harvard University. He currently also serves on the board of Digene Corporation.

Member of the Audit Committee

Member of the Nominating and Governance Committee

Maria Sainz
Director

Ms. Sainz was elected to the Orthofix International Board of Directors in 2008. She currently serves as the President and CEO of Concentric Medical. Prior to joining Concentric Medical she was President of Guidant Corporation's Cardiac Surgery Division and a member of Guidant's Management Committee prior to their acquisition by Boston Scientific. She gained significant experience in the medical device market with Lilly MDD, Guidant and Boston Scientific. Ms. Sainz holds a Bachelors and Masters Degree of Arts from the Universidad Complutense de Madrid, and a Masters Degree in International Management from AGSIM in Arizona.

Member of the Compensation Committee

Michael R. Mainelli
Director

Mr. Mainelli was elected to the Orthofix International Board of Directors in 2009. He currently serves as the President and CEO of Active Implants Corporation. He was formerly an executive officer at Stryker Corporation, serving as President-Stryker Spine, President-Stryker Japan and initially as VP-Corporate Development and Assistant to the Chairman. Prior to joining Stryker he was a marketing and product management executive in the Global Magnetic Resonance Business at GE Medical Systems, now called GE Healthcare. Mr. Mainelli holds a MBA from the University of Chicago, a MSE from the University of Pennsylvania and a BSME from Northeastern University.

Member of the Compensation Committee